1 min to read News Posted on February 8, 2023 Takeda Completes Acquisition of Nimbus Therapeutics' TYK2 Program Subsidiary – Marketscreener.com Takeda Completes Acquisition of Nimbus Therapeutics' TYK2 Program Subsidiary Marketscreener.com Source: Takeda Completes Acquisition of Nimbus Therapeutics' TYK2 Program Subsidiary – Marketscreener.com share tweet share Report: SPACs and De-SPACing: Considerations for Going Public Through a Combination with a SPACBy the Numbers: Four Practices Big Law Firms Need to Power 2023 – Bloomberg LawHow a SPAC works?Why Buy a SPAC Before It Identifies a Target? Tags: SPACs